Willkie and co-counsel Manatt secured a precedent-setting award of legal fees and costs that Blake Lively incurred in defeating a defamation countersuit in her high-profile litigation with Justin Baldoni, Lively’s co-star and director of It Ends With Us.   On June 12, Judge Lewis Liman...

Michael S. Schachter, partner and Co-Chair of Willkie's White-Collar Defense Practice Group, has been honored by UJA-Federation of New York for his leadership in the law, service to the community and commitment to helping those in need. Mike was recognized for his professional excellence...

Willkie is representing FTV Capital in the sale of its portfolio company Liberis, a leading global embedded finance platform, to Nordic Capital.    Nordic Capital recently announced that it agreed to acquire Liberis and will combine the business with Qred, one of Europe's foremost digital...

Willkie and co-counsel Manatt were recognized with a “Shout-Out” in The AmLaw Litigation Daily for securing a precedent-setting award of legal fees and costs that Blake Lively incurred in defeating a defamation countersuit in her high-profile litigation with Justin Baldoni, Lively’s co-star...

On July 2 at 4:15 PM (BST), partner Dharshini Prasad, London Chair of the International Arbitration Practice Group, will participate in "The GAR Live: Debate" as part of the GAR Live: Energy Disputes 2026 event hosted in London, UK.   The session features two teams arguing for or against...

Willkie is representing Blue Wolf Capital Partners LLC, majority owner of LOGISTEC, a multi-purpose terminal operator and logistics service provider, in the sale of LOGISTEC’s marine terminal division to Enstructure, one of North America’s leading terminal and logistics companies. Blue...

Five Willkie attorneys have been named to the 2026 Lawdragon 500 Leading Global IP Lawyers, an annual guide to the top intellectual property litigators, dealmakers, and strategists worldwide.   The five partners are recognized for "protecting innovation, defending brand integrity and...

Willkie represented GMS Ventures and Investments, the largest stockholder of Outlook Therapeutics, Inc. (Nasdaq: OTLK), in a $5.0 million registered direct offering of common stock.    Pursuant to a securities purchase agreement dated May 28, 2026, GMS Ventures and Investments purchased...